Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: a prospective cohort study

BACKGROUND: Carbohydrate antigen 19-9 (CA19-9) is the only biomarker for monitoring responses during treatments of pancreatic cancer, but its accuracy for disease outcome is controversial. Fluid biopsy is a new method for diagnosis and monitoring treatment response. In this study, we investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chien-Jui, Huang, Wen-Yen, Chen, Chien-Yu, Chao, Ying-Jui, Chiang, Nai-Jung, Shan, Yan-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210094/
https://www.ncbi.nlm.nih.gov/pubmed/35747164
http://dx.doi.org/10.1177/17588359221106558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210094/
https://www.ncbi.nlm.nih.gov/pubmed/35747164
http://dx.doi.org/10.1177/17588359221106558

Ejemplares similares